Luminescent dinuclear copper(I) complexes bearing an imidazolylpyrimidine bridging ligand

The synthesis and photophysical study of two dinuclear copper(I) complexes bearing a 2-(1H-imidazol-2-yl)pyrimidine bridging ligand are described. The tetrahedral coordination sphere of each copper center is completed through the use of a bulky bis(phosphine) ligand, either DPEphos or Xantphos. Temperature-dependent photophysical studies demonstrated emission through a combination of phosphorescence and thermally activated delayed fluorescence for both complexes, and an intense emission (ΦPL = 46%) was observed for a crystalline sample of one of the complexes reported. The photophysics of these two complexes is very sensitive to the environment. Two pseudopolymorphs of one of the dinuclear complexes were isolated, with distinct photophysics. The emission color of the crystals can be changed by grinding, and the differences in their photophysics before and after grinding are discussed.

Citation

Li , C , Li , W , Henwood , A F , Hall , D , Cordes , D B , Slawin , A M Z , Lemaur , V , Olivier , Y , Samuel , I D W & Zysman-Colman , E 2020 , ' Luminescent dinuclear copper(I) complexes bearing an imidazolylpyrimidine bridging ligand ' , Inorganic Chemistry , vol. Article ASAP . https://doi.org/10.1021/acs.inorgchem.0c01866

Publication

Inorganic Chemistry

Status

Peer reviewed

DOI

https://doi.org/10.1021/acs.inorgchem.0c01866

ISSN

0020-1669

Type

Journal article

Rights

Copyright © 2020 American Chemical Society. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at https://doi.org/10.1021/acs.inorgchem.0c01866

Description

Funding: C.Li thanks the Prof. & Mrs. Purdie Bequests Scholarship and AstraZeneca for a PhD Studentship. We are grateful to the Engineering and Physical Sciences Research Council of the UK (EPSRC) for financial support (grants EP/R035164/1 and EP/P010482/1). We acknowledge the EPSRC UK National Mass Spectrometry Facility at Swansea University for mass spectrometry analysis. The work in Mons was supported by the European Commission / Région Wallonne (FEDER –BIORGEL project), the Consortium des Équipements de Calcul Intensif (CÉCI), funded by the Fonds National de la Recherche Scientifique (F.R.S.-FNRS) under Grant No. 2.5020.11 as well as the Tier-1 supercomputer of the Fédération Wallonie-Bruxelles, infrastructure funded by the Walloon Region under Grant Agreement n1117545, and FRS-FNRS.

Collections

University of St Andrews Research

URI

http://hdl.handle.net/10023/23876